AGEIST The Future of Personalized Health Is Here Today: Dr. Momo Vuyisich
How can we test our gut microbiome and what can we do with the results? What is our oral microbiome? How is Viome revolutionizing cancer and disease detection, prevention, and elimination? What is Dr. Momo’s vision for the future of health?
Dr. Momo Vuyisich is the Co-founder, Chief Science Officer, and Head of Clinical Research at Viome Life Sciences whose mission is to digitize, decode, and decipher human biology for the prevention, early diagnosis, and treatment of chronic diseases and cancer. AGEIST founder David Stewart is a testimony of Viome’s ability to help us reach optimal health.
Dr. Momo explains the science behind Viome’s technology, the individualized approach to Viome’s treatment plans, how they are revolutionalizing the detection of oral & throat cancer, the importance of our oral microbiome, Dr. Momo’s vision for the next 10 years, and more.
SuperAge listeners receive $30 off Viome’s Health Intelligence Test here. Use code “AGEIST”.
“No matter what condition you are looking at, you should look at the whole body and not just the isolated organ.
“The process of digestion starts in the mouth, there are enzymes that are released in the mouth and there are both microbial and human enzymes.”
“I wanted to create a technology that is advanced and molecular and super hard to do but be accessible to everyone in the world just like the app store.”
“We are focusing on preventative and curative strategies and not these maintenance strategies where you’re given medication for the rest of your life and you still are deteriorating or you’re still not getting better.”
“Symptoms are the terminal stages of a disease. Molecular disease happens years oor decades before the symptoms are felt. If you want to know your status that you are heading for a heart attack, you can know that 30 years before the heart attack.”
Listen to the SuperAge podcast wherever you get your pods.
Connect with Dr. Momo:
LinkedIn
Viome Life Sciences